• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    More On MBLTY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Mesoblast Limited (MBLTY)

    -Other OTC
    12.75 Up 0.55(4.51%) Aug 28, 10:11AM EDT
    Add to Portfolio
    Prev Close:12.20
    Open:12.75
    Bid:N/A
    Ask:N/A
    1y Target Est:37.02
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:12.75 - 12.75
    52wk Range:10.27 - 27.01
    Volume:465
    Avg Vol (3m):968
    Market Cap:850.41M
    P/E (ttm):N/A
    EPS (ttm):-1.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):38.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-16) :-1.48
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative therapeutic cell-based products in Australia, the United States, and Singapore. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback